These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20553211)

  • 1. The origins of urothelial carcinoma.
    Cheng L; Davidson DD; Maclennan GT; Williamson SR; Zhang S; Koch MO; Montironi R; Lopez-Beltran A
    Expert Rev Anticancer Ther; 2010 Jun; 10(6):865-80. PubMed ID: 20553211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art.
    Williamson SR; Montironi R; Lopez-Beltran A; MacLennan GT; Davidson DD; Cheng L
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):112-26. PubMed ID: 20097572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pagetoid variant of bladder urothelial carcinoma in situ A clinicopathological study of 11 cases.
    Lopez-Beltran A; Luque RJ; Moreno A; Bollito E; Carmona E; Montironi R
    Virchows Arch; 2002 Aug; 441(2):148-53. PubMed ID: 12189504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of bovine urothelial tumours and tumour-like lesions of the urinary bladder.
    Roperto S; Borzacchiello G; Brun R; Leonardi L; Maiolino P; Martano M; Paciello O; Papparella S; Restucci B; Russo V; Salvatore G; Urraro C; Roperto F
    J Comp Pathol; 2010; 142(2-3):95-108. PubMed ID: 19818448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
    Blanes A; Rubio J; Sanchez-Carrillo JJ; Diaz-Cano SJ
    Hum Pathol; 2009 Jul; 40(7):988-97. PubMed ID: 19368958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
    Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
    Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flat intraepithelial lesions of the urinary bladder.
    Cheng L; Cheville JC; Neumann RM; Bostwick DG
    Cancer; 2000 Feb; 88(3):625-31. PubMed ID: 10649257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.
    Ren H; Yuan Z; Waltzer W; Shroyer K; Pan Y
    J Urol; 2010 Oct; 184(4):1499-506. PubMed ID: 20723922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
    Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraepithelial lesions of urinary bladder: morphologic considerations.
    Murphy WM; Busch C; Algaba F
    Scand J Urol Nephrol Suppl; 2000; (205):67-81. PubMed ID: 11144906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.